Question 1

Berapa harga saham Johnson & Johnson hari ini?

Accepted Answer

Harga semasa Johnson & Johnson ialah 237.04 USD — ia telah menurun sebanyak -1.27% dalam 24 jam yang lepas. Lihat prestasi harga saham Johnson & Johnson dengan lebih teliti pada grafik lanjutan.

Question 2

Apakah simbol saham Johnson & Johnson?

Accepted Answer

Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa NYSE, saham Johnson & Johnson diniagakan dengan simbol JNJ.

Question 3

Adakah harga saham JNJ sedang naik?

Accepted Answer

Saham JNJ telah menurun sebanyak -1.05% dalam minggu lepas, telah menurun sebanyak -1.87% dalam bulan lepas, dan telah meningkat sebanyak 53.56% dalam tahun lepas. Lihat lebih banyak data pada grafik JNJ.

Question 4

Apakah cadangan penganalisis untuk JNJ?

Accepted Answer

Setakat 15 Apr 2026, daripada 9 cadangan penganalisis, majoriti memberi penarafan JNJ sebagai buy.

Question 5

Apakah nilai pasaran JNJ?

Accepted Answer

Setakat hari ini, JNJ mempunyai kapitalisasi pasaran sebanyak 573.46B USD. Jelajahi senarai saham kami yang diatur mengikut kapitalisasi pasaran untuk membandingkan JNJ dengan saham lain.

Question 6

Adakah JNJ mengeluarkan laporan kewangan?

Accepted Answer

Ya, anda boleh menjejaki kewangan JNJ dalam laporan tahunan dan suku tahunan di Profit.com.

Question 7

Bila tarikh laporan pendapatan seterusnya JNJ?

Accepted Answer

JNJ akan mengeluarkan laporan pendapatan seterusnya pada -. Jejak acara yang akan datang dengan Kalendar Pendapatan kami.

Question 8

Berapa pendapatan JNJ untuk suku tahunan lepas?

Accepted Answer

JNJ melaporkan pendapatan sebanyak $2.46 setiap saham untuk suku tahunan lepas, lebih rendah daripada anggaran $2.46 setiap saham, menghasilkan kejutan -. Pendapatan yang dianggarkan untuk suku tahunan akan datang adalah $2.68 setiap saham. Lihat butiran lanjut tentang pendapatan JNJ di Profit.com.

Question 9

Berapa hasil JNJ untuk suku tahunan lepas?

Accepted Answer

Hasil JNJ untuk suku tahunan lepas ialah 24.56B USD, lebih rendah daripada anggaran 25.33B USD. Hasil yang dianggarkan untuk suku tahunan akan datang ialah 25.15B USD. Lihat lebih banyak statistik dalam laporan kewangan JNJ di Profit.com.

Question 10

Berapa Pendapatan Bersih JNJ untuk suku tahunan lepas?

Accepted Answer

Pendapatan bersih JNJ untuk suku tahunan lepas adalah 5.12B USD, manakala suku tahunan sebelumnya menunjukkan pendapatan bersih sebanyak 5.15B USD, yang mencatatkan perubahan sebanyak -0.70%. Lihat lebih banyak statistik dalam laporan kewangan JNJ di Profit.com.

Question 11

Adakah JNJ membayar dividen?

Accepted Answer

Tidak, JNJ tidak membayar sebarang dividen kepada pemegang sahamnya. Tetapi anda boleh meneroka senarai stok berdividen tinggi di Profit.com.

Question 12

Berapa ramai pekerja yang ada di JNJ?

Accepted Answer

Sehingga 15 Apr 2026, JNJ menggaji kira-kira 138200 pekerja. Lihat jika JNJ berada dalam senarai majikan terbesar kami.

Question 13

Apakah EBITDA JNJ?

Accepted Answer

EBITDA, yang mengukur prestasi operasi syarikat, mencerminkan peningkatan kecekapan. EBITDA JNJ ialah 33.84B USD, dengan margin EBITDA semasa sebanyak 28.46%. Lihat lebih banyak statistik dalam laporan kewangan JNJ di Profit.com.

Question 14

Bagaimana untuk membeli saham JNJ?

Accepted Answer

Seperti saham lain, saham JNJ diperdagangkan di bursa saham seperti NYSE. Cara paling mudah untuk membelinya adalah melalui broker saham dalam talian. Buka akaun, ikuti prosedur broker, dan mula berdagang. Sebagai alternatif, anda boleh berlatih berdagang saham Tesla di Profit.com dalam Playtrade Tournaments atau pilih broker yang disyorkan untuk berdagang terus.

Question 15

Patutkah saya melabur dalam saham JNJ?

Accepted Answer

Melabur dalam saham memerlukan penyelidikan yang teliti, termasuk menganalisis kewangan syarikat, berita berkaitan, dan analisis teknikal. Pada masa ini, cadangan penganalisis teknikal Tesla menunjukkan penarafan buy.

Sebelum melabur dalam JNJ, pertimbangkan untuk melanggan Profit PRO di mana anda boleh berlatih berdagang dalam Playtrade Tournaments, mengakses pandangan pasaran harian yang digerakkan oleh AI, menyalin Watchlists yang dipilih dengan teliti, dan mengikuti Portfolia Bilionaire.

Johnson & Johnson

⚠️BREAKING: *JOHNSON &amp; JOHNSON 1Q EPS $2.70; EST. $2.68 *JNJ 1Q REVENUE $24.1B; EST. $23.6B $JNJ https://t.co/p83xzBGvxN

Johnson & Johnson considering sale of orthopedics business - report

Johnson & Johnson strikes deal with U.S. government to lower drug prices - CNBC

Johnson & Johnson halts mid-stage trial of experimental eczema drug - CNBC

Johnson & Johnson to buy Halda Therapeutics for $3.05B

⚠️BREAKING: *JOHNSON &amp; JOHNSON 2Q EPS $2.77; EST. $2.68 *JNJ 2Q REVENUE $23.73B; EST. $22.86B $JNJ https://t.co/o73iKfdkiJ

Ethereum Market Cap Surges to $375.5 Billion, Surpassing Johnson & Johnson and Ranking 30th Globally

Johnson & Johnson raises sales outlook, even with tariff costs accounted for

Jim Cramer's week ahead: Earnings from Goldman Sachs, Johnson & Johnson and Netflix

Johnson & Johnson made approach to Intra-Cellular 6 weeks to 2 months ago - report

M&A Snapshot: Johnson & Johnson to acquire Intra-Cellular Therapies in $14.6B CNS-focused deal

Johnson & Johnson makes $15 billion bet on mental-health drugs

Johnson & Johnson exploring takeover of Intra-Cellular - Bloomberg

⚠️BREAKING: *JOHNSON &amp; JOHNSON 3Q EPS $2.42, EST. $2.19 *JNJ 3Q REVENUE $22.50B, EST. $22.17B $JNJ https://t.co/vHWup1EcBA

Johnson & Johnson stock seesaws lower after profit beat, but outlook was lowered

Johnson & Johnson closes acquisition of biotechnology company Proteologix

Johnson & Johnson to buy dermatology-focused biotech Proteologix

Johnson & Johnson tops quarterly profit estimates as medical device sales jump

Johnson & Johnson to acquire Shockwave Medical for $13.1B in cash

Shockwave Medical surges as Johnson & Johnson in talks to acquire - report

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million - CNBC

⚠️BREAKING: *JOHNSON &amp; JOHNSON 4Q EARNINGS PER SHARE $2.29, EST. $2.28 *JNJ 4Q REV. $21.4B, EST. $21.0B https://t.co/AFYNc3kGXQ 👈 $JNJ https://t.co/MlRGdm66vW

Johnson & Johnson earnings beat estimates with boost from medtech sales

Major Earnings Releases For Tuesday 23rd Of January: $GE $JNJ $MMM $DHI $HAL $PG $RTX $VZ $LMT $NFLX https://t.co/uBEPebRUJu

Johnson & Johnson to acquire ADC developer Ambrx Biopharma for $2B

$JNJ $TEVA | Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity https://t.co/VVRJKLX2Vh

Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge

Earnings Watch: Johnson & Johnson earnings: What to expect

Cramer sours on Johnson & Johnson as lawsuits pile up

Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time

Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer

Johnson & Johnson launches Kenvue exchange offer (NYSE:JNJ) - Seeking Alpha

Stocks making the biggest moves midday: Netflix, American Airlines, Johnson & Johnson and more

*U.S. FDA REVOKES EMERGENCY USE AUTHORIZATION FOR J&J'S COVID VACCINE https://t.co/CFKEtW5IjL $JNJ https://t.co/6tcyE2yjgJ

Johnson & Johnson's consumer health unit Kenvue started trading. What it means for J&J shareholders like us - CNBC

Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO - CNBC

Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says

4 Stock Market Morning Movers: $NVDA $BLU $GS $JNJ Check out the Details 👇 https://t.co/zxQGPEOfWa

The markets are open!🔔 Here are some things in focus today.👇 ✧ Building permits (Mar) ✦ Housing starts (Mar) ✧ Fed Bowman speech ✦ $NFLX, $GS, $BAC, $JNJ, $LMT, $ISRG, $UAL, and more earnings! https://t.co/XyPV5QWJw8

Johnson & Johnson swings to loss as it books multibillion-dollar charge to settle talc claims

Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and more - CNBC

⚠️BREAKING: *JOHNSON & JOHNSON 1Q EARNINGS PER SHARE $2.68, EST. $2.50 *JOHNSON & JOHNSON 1Q REV. $24.7B, EST. $23.6B https://t.co/upc7H4lBiI $JNJ https://t.co/0tdJfX6bwq

Major #Earnings Releases Tuesday 18th April $JNJ $BAC $NFLX $LMT $GS $UAL https://t.co/IJD8JKvzpK

first full week of #earnings season https://t.co/lObOE0dgsr $TSLA $SCHW $BAC $NFLX $JNJ $GS $MTB $STT $TSM $ASML $LMT $MS $UAL $AXP $RAD $T $BK $PLD $GNTY $IBM $USB $NOK $PG $ERIC $ISRG $NDAQ $BKR $ABT $ALK $SLB $ALLY $MBWM $WAL $FCX $BX $JBHT $UNP $CBSH $DHI $PM $ELV $AA… https://t.co/CDZXPSGHTx

JNJ, AbbVie plan to pull US accelerated approvals for some blood cancer treatments https://t.co/6k1Mj4IbBf https://t.co/zjQf97LRpd

Soalan Lazim

⚠️BREAKING: JOHNSON & JOHNSON 1Q EPS $2.70; EST. $2.68 JNJ 1Q REVENUE $24.1B; EST. $23.6B $JNJ https://t.co/p83xzBGvxN

⚠️BREAKING: JOHNSON & JOHNSON 2Q EPS $2.77; EST. $2.68 JNJ 2Q REVENUE $23.73B; EST. $22.86B $JNJ https://t.co/o73iKfdkiJ

⚠️BREAKING: JOHNSON & JOHNSON 3Q EPS $2.42, EST. $2.19 JNJ 3Q REVENUE $22.50B, EST. $22.17B $JNJ https://t.co/vHWup1EcBA

⚠️BREAKING: JOHNSON & JOHNSON 4Q EARNINGS PER SHARE $2.29, EST. $2.28 JNJ 4Q REV. $21.4B, EST. $21.0B https://t.co/AFYNc3kGXQ 👈 $JNJ https://t.co/MlRGdm66vW

⚠️BREAKING: JOHNSON & JOHNSON 1Q EARNINGS PER SHARE $2.68, EST. $2.50 JOHNSON & JOHNSON 1Q REV. $24.7B, EST. $23.6B https://t.co/upc7H4lBiI $JNJ https://t.co/0tdJfX6bwq